Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Allergic Rhinitis
Open-data reference.
24 US clinical trials · 2 currently recruiting
Active & Recent Trials
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?
Northwell Health
NCT05287841
Viral Mucosal Reprogramming
The University of Texas Medical Branch, Galveston
NCT05331170
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
House Ear Institute
NCT04815187
Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies
Greer Laboratories
NCT00599872
3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis
Meda Pharmaceuticals
NCT01794741
Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis
Regeneron Pharmaceuticals
NCT04709575
Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine
Sanofi
NCT00636870
Dupilumab As An Adjunct For Subcutaneous Grass Immunotherapy
Regeneron Pharmaceuticals
NCT03558997
Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
Alcon Research
NCT00772304
Comparability and Standardization of Controlled Allergen Challenge Facilities
Queen's University
NCT02543346
Validation of Laser Doppler Flowmetry to Identify Allergic Rhinitis Patients With Pharmacogenetic Alterations in Histamine Metabolism
Children's Mercy Hospital Kansas City
NCT00362999
A Study Evaluating Effects of Intranasal JNJ-17166864 on Symptoms of Allergic Rhinitis in Adults
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
NCT00604123
Association of Transcutaneous Pulse CO-oximetry With Inflammatory Lung Diseases
Boston Children's Hospital
NCT02831348
Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without Allergies
University of North Carolina, Chapel Hill
NCT00617110
Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by Histamine
Sanofi
NCT00637585
The Effect of Cetirizine on Bronchoconstriction
New York City Health and Hospitals Corporation
NCT03340740
Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)
Covis Pharma S.à.r.l.
NCT00458835
Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis
West Penn Allegheny Health System
NCT01550471
A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device
Immunomic Therapeutics
NCT02146781
Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis
University of Chicago
NCT02402465
Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)
University of Chicago
NCT00791102
The Effect of Omalizumab on Responses to Cat Allergen Challenge
Johns Hopkins University
NCT00604786
Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash
Drexel University
NCT01647633
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
University of California, Davis
NCT00367016
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 2 |
| Phase 2 | 4 |
| Phase 3 | 3 |
| Phase 4 | 10 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Allergic Rhinitis Trial Landscape
ClinicalTrials.gov lists 24 US studies indexed under Allergic Rhinitis, and 2 of those are currently open to recruitment — roughly 8% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Allergic Rhinitis shows 13 late-stage studies (Phase 3 and Phase 4 combined) alongside 6 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Allergic Rhinitis is led by Sanofi with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 24 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Allergic Rhinitis?
PlainTrial tracks 24 US clinical trials for Allergic Rhinitis, of which 2 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Allergic Rhinitis?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.